Here we show that treatment with methotrexate (MTX), an agent used for the long-term treatment of patients with rheumatoid arthritis and found to decrease cellular methylation including DNA methylation, also results in FMR1 expression but no detectable FMRP levels [16-18]. The gene discussed is FMR1; the disease is rheumatoid arthritis.